Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular events
- 18 January 2021
- journal article
- letter
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 84 (6), e279-e280
- https://doi.org/10.1016/j.jaad.2021.01.043
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryJournal of the American Academy of Dermatology, 2020
- Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitisBritish Journal of Dermatology, 2018
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?British Journal of Dermatology, 2018
- Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitisJournal of the American Academy of Dermatology, 2017